tiprankstipranks
Trending News
More News >
Cidara Therapeutics (CDTX)
NASDAQ:CDTX

Compare Cidara Therapeutics (CDTX) vs. Competitors

Compare
862 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Cidara Therapeutics
$221.38
$6.96B
-18.79
725.74%
0 Buy
5 Hold
0 Sell
Hold
Catalyst Pharma
$22.60
$2.79B
13.19
-0.88%
5 Buy
0 Hold
0 Sell
Strong Buy
IDEAYA Biosciences
$36.43
$3.32B
-19.64
46.60%
13 Buy
2 Hold
0 Sell
Strong Buy
Arcutis Biotherapeutics
$29.88
$3.62B
-84.29
95.68%
7 Buy
1 Hold
0 Sell
Strong Buy
Beam Therapeutics
$28.93
$2.94B
-6.31
4.48%
11 Buy
3 Hold
0 Sell
Strong Buy
Tarsus Pharmaceuticals
$78.08
$3.31B
-38.84
41.58%
6 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CDTX
Cidara Therapeutics
221.38
197.38
822.42%
CPRX
Catalyst Pharma
22.60
0.68
3.10%
IDYA
IDEAYA Biosciences
36.43
12.40
51.60%
ARQT
Arcutis Biotherapeutics
29.88
16.07
116.36%
BEAM
Beam Therapeutics
28.00
1.61
6.10%
TARS
Tarsus Pharmaceuticals
78.21
25.52
48.43%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts